About BMC, Div. of Ped Infectious Diseases
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Institute of Allergy and Infectious Diseases (NIAID)
19
Clinical Trials at BMC, Div. of Ped Infectious Diseases
During the past decade, BMC, Div. of Ped Infectious Diseases conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT
1995-06-01
Completed
140
Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection
1998-06-01
Completed
96
A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection
1996-02-01
Completed
72
A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers
1999-01-01
Completed
156
A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV Infection
1998-07-01
Completed
230
A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease
1998-03-01
Completed
32
A Phase I/II Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected Children
1998-04-01
Completed
45
A Study of the Safety and Effectiveness of a Chickenpox Vaccine in HIV-Infected Children
2005-11-01
Completed
127
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "BMC, Div. of Ped Infectious Diseases"
#1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 8 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Glaxo Wellcome" with 2 trials as a collaborator and "Hoffmann-La Roche" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at BMC, Div. of Ped Infectious Diseases
According to Clinical.Site data, the most researched conditions in "BMC, Div. of Ped Infectious Diseases" are
"HIV Infections" (19 trials), "Cytomegalovirus Infections" (2 trials), "Chickenpox" (1 trials), "HIV Seronegativity" (1 trials) and "Hepatitis B" (1 trials). Many other conditions were trialed in "BMC, Div. of Ped Infectious Diseases" in a lesser frequency.
Clinical Trials Intervention Types at BMC, Div. of Ped Infectious Diseases
Most popular intervention types in "BMC, Div. of Ped Infectious Diseases" are "Drug" (11 trials) and "Biological" (8 trials). Other intervention types were less common.
The name of intervention was led by "Zidovudine" (5 trials), "Lamivudine" (2 trials), "Nelfinavir mesylate" (2 trials), "Nevirapine" (2 trials) and "Stavudine" (2 trials). Other intervention names were less common.
Clinical Trials Genders at BMC, Div. of Ped Infectious Diseases
The vast majority of trials in "BMC, Div. of Ped Infectious Diseases" are
18 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at BMC, Div. of Ped Infectious Diseases
Currently, there are NaN active trials in "BMC, Div. of Ped Infectious Diseases".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 19 completed trials in BMC, Div. of Ped Infectious Diseases,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in BMC, Div. of Ped Infectious Diseases, 9 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".